After the market closed Wednesday, California-based Amgen, Inc. (NASDAQ:AMGN) announced an increase in net income for their third quarter. Net income totaled $1.16 billion, or $1.09 per share, compared to $201 million, or 18 cents per share, in their third quarter last year. Excluding one-time items the drugmaker would have earned $1.23 per share, beating Street estimates of $1.08 per share. Sales during the period increased 7 percent to reach $3.87 billion. The company expects revenue for the year to be between $14.9 billion and $15.2 billion. Amgen shares were down $2.30 to $50.03 when the day ended.

Contact Chip Brian

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html